Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, Elizabeth M. Park et al.|Cancer Cell|2021Cited by 930
Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitorKavya Ramkumar, Nouri Neamati|Nature Communications|2016Cited by 74